Keikawus Arastéh - Articles and news items

Boehringer Ingelheim logo

Viramune® (nevirapine) prolonged-release once-daily formulation receives approval in the EU

Industry news, News / 21 September 2011 / Boehringer Ingelheim

Once-daily Viramune® (nevirapine) prolonged-release has received approval…

Boehringer Ingelheim logo

Viramune® (nevirapine) receives CHMP recommendation for approval

Industry news, News / 27 July 2011 / Boehringer Ingelheim

The CHMP issued a Positive Opinion recommending the approval of Viramune® (nevirapine)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+